The First Reported Case of Infant Soft Tissues Infection Caused by Legionella Maceachernii: A Case Report and Literature Review
Abstract
Abstract Legionella spp. predominantly Legionella pneumophila, are recognized respiratory pathogens, while soft tissue infections caused by non-pneumophila species remain exceptionally rare. We present the first documented case of L. maceachernii soft tissue infection in an infant worldwide. The patient presented with fever accompanied by occipital, anterior thoracic, and wrist masses. Diagnosis was confirmed through metagenomic next-generation sequencing (mNGS) of tissue samples with histopathological correlation. Initial empiric therapy with vancomycin and cefotaxime yielded no clinical improvement. Subsequent mNGS analysis of cerebrospinal fluid and lesional tissue identified L. maceachernii infection, prompting targeted antimicrobial therapy with levofloxacin and rifampicin that resulted in clinical resolution. A review of historical cases reveals that Legionella soft tissue infections typically occur in immunocompromised hosts or those receiving immunosuppressive therapies, and this association prompted an investigation into possible congenital immunodeficiency in our patient. Whole exome sequencing coupled with Sanger sequencing validation identified a pathogenic mutation in the IL2RG gene, confirming X-linked severe combined immunodeficiency (X-SCID) in the infant and carrier status in the mother. This case highlights three paradigm-shifting concepts in pediatric infectious disease management, including 1) L. maceachernii should be included in the differential…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.